Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Yield10 Bioscience Inc YTEN

Yield10 Bioscience, Inc. is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa (Camelina) as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and... see more

Recent & Breaking News (OTCQB:YTEN)

Yield10 Bioscience, Inc. to Present at the Ladenburg Thalmann Technology Expo 2019 on May 30, 2019

GlobeNewswire May 28, 2019

Yield10 Bioscience Announces First Quarter 2019 Financial Results

GlobeNewswire May 9, 2019

Yield10 Bioscience Signs Exclusive Worldwide License with University of Missouri for Advanced Technology Used to Boost Oil Content in Crops

GlobeNewswire May 8, 2019

Yield10 Bioscience to Announce First Quarter 2019 Financial Results and Host a Conference Call on Thursday, May 9, 2019

GlobeNewswire May 1, 2019

Yield10 Bioscience Announces Notice of Allowance for U.S. Patent Covering Crop Yield Trait C3003

GlobeNewswire April 23, 2019

Yield10 Bioscience CEO Oliver Peoples to Present at the Advanced Bioeconomy Leadership Conference on April 3, 2019

GlobeNewswire April 2, 2019

Yield10 Bioscience Announces Fourth Quarter and Full Year 2018 Financial Results

GlobeNewswire March 25, 2019

Yield10 Bioscience to Present at the Spring Investor Summit on April 2, 2019

GlobeNewswire March 21, 2019

Yield10 Bioscience to Hold Fourth Quarter and Full Year 2018 Financial Results Conference Call on Monday, March 25, 2019, at 4:30 p.m. EDT

GlobeNewswire March 19, 2019

Yield10 Bioscience Announces Pricing of $2.9 Million Registered Direct Offering

GlobeNewswire March 15, 2019

Yield10 Bioscience Initiates Early Development Program in Corn to Evaluate Novel Traits

GlobeNewswire January 22, 2019

Yield10 Bioscience Reports Encouraging Results from 2018 Field Tests of C3003 and Announces Advancement of C3003 into Commercial Development for Canola

GlobeNewswire January 15, 2019

Yield10 Bioscience Names Sherri M. Brown, Ph.D., Former Monsanto Executive, as Special Commercial and Technical Advisor

GlobeNewswire December 13, 2018

Yield10 Bioscience Announces Third Quarter 2018 Financial Results

GlobeNewswire November 8, 2018

Yield10 Bioscience to Host Webcast of its Third Quarter 2018 Conference Call

GlobeNewswire October 30, 2018

Yield10 Bioscience Obtains Nonregulated Status for its Novel CRISPR-Cas9 Triple Gene Edited Camelina Plant Lines to Boost Seed Oil Content

GlobeNewswire October 2, 2018

Yield10 Bioscience to Present at the Ladenburg Thalmann 2018 Healthcare Conference  

GlobeNewswire September 25, 2018

Yield10 Bioscience Grants Research License to Forage Genetics to Evaluate Novel Yield Traits in Sorghum

GlobeNewswire September 21, 2018

Yield10 Bioscience Researcher Dr. Meghna Malik to Present at the 26th CAOCS Canadian Lipid and Bioresource Conference 2018

GlobeNewswire September 10, 2018

Yield10 Bioscience Reports Promising Seed Yield Results for Novel Yield Trait C3004 in Growth Chamber Studies in Camelina

GlobeNewswire September 5, 2018